{"id":22440,"date":"2024-09-16T13:14:52","date_gmt":"2024-09-16T17:14:52","guid":{"rendered":"https:\/\/cutheme.local\/coris\/?p=22440"},"modified":"2026-03-18T09:31:01","modified_gmt":"2026-03-18T13:31:01","slug":"canadian-hemophilia-society-bayer-advance-canada-research-program","status":"publish","type":"post","link":"https:\/\/research.carleton.ca\/coris\/2024\/canadian-hemophilia-society-bayer-advance-canada-research-program\/","title":{"rendered":"Canadian Hemophilia Society – Bayer – ADVANCE Canada Research Program"},"content":{"rendered":"\n
\n
\n\n
\n
\n
\n

\n Canadian Hemophilia Society – Bayer – ADVANCE Canada Research Program\n <\/h1>\n \n \n <\/header>\n\n <\/div>\n\n <\/div>\n\n <\/div>\n<\/section>\n\n
\n
\n

Funder’s Website<\/h2>\n

The funder’s website can be found HERE<\/a><\/strong>.<\/p>\n

Funding Value and Duration<\/h2>\n

The primary intent of this program is to offer one or two $22,500 research grants, to a maximum of $45,000 for one year.<\/p>\n

Depending upon the number and quality of applications, funding for different amounts is possible, as is the offering of more than one research grant, within however, the allotted total budget stated above.<\/p>\n

Overview<\/h2>\n

The Canadian Hemophilia Society \u2013 Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population. The research program will support studies that aim to:<\/p>\n